Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.

Source:http://linkedlifedata.com/resource/pubmed/id/17905106

Download in:

View as

General Info

PMID
17905106